Portfolio Company News

Veralox Therapeutics Announces Closing Of $16.6 Million Series A Financing And Announces New Board Members

June 16, 2021

Standard Bariatrics Secures $35M in Series B Funding to Accelerate Development and Commercialization of Their First Bariatric Surgical Platform for Sleeve Gastrectomy

June 1, 2021

CROs dMed and Clinipace Merge to Accelerate Customer Success

April 28, 2021

Artizan Biosciences Closes $11 Million Series A-2 Financing and Enters Option and License Agreement with Biohaven Therapeutics

March 2, 2021

contact

team

dedicated funds

news

home

portfolio